LUNG - Pulmonx Corp
Pulmonx Corp Logo

LUNG - Pulmonx Corp

https://pulmonx.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.

52W High
$9.37
52W Low
$1.47
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.43
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
28.33
EV/EBITDA (<8 favorable)
-5.62
EV/Revenue (<3 favorable)
0.48
P/S (TTM) (<3 favorable)
0.78
P/B (<3 favorable)
1.03
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
4.27%
Institutions (25–75% balanced)
89.54%
Shares Outstanding
40,746,600
Float
39,663,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
90,549,000
Gross Profit (TTM)
66,162,000
EPS (TTM)
-1.43
Profit Margin (>10% good)
-0.63%
Operating Margin (TTM) (higher better)
-0.62%
ROE (TTM) (>15% strong)
-0.67%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.15
Momentum
Bearish momentum
Value
-0.1097
Previous
-0.1196
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025